Juvenile Idiopathic Arthritis Diagnostic Market Size to Exceed $6.31 Billion by 2029 | Growth and Industry Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Juvenile Idiopathic Arthritis Diagnostic Market Grown from 2024 to 2025?
The market size for diagnosing juvenile idiopathic arthritis has experienced significant growth in the past few years. A rise from $4.75 billion in 2024 to $5.04 billion in 2025, a compound annual growth rate (CAGR) of 6.1%, is projected. This growth during the historic period is largely down to an increased prevalence of juvenile idiopathic arthritis, a heightened understanding of pediatric autoimmune conditions, early diagnosis, an increase in healthcare investments, and a growing emphasis on child healthcare.
What Growth Rate Is Anticipated for the Juvenile Idiopathic Arthritis Diagnostic Market in the Coming Years?
In the upcoming years, the juvenile idiopathic arthritis diagnostic market is projected to witness substantial growth, elevating to $6.32 billion in 2029 with a compound annual growth rate (CAGR) of 5.8%. The envisaged growth in this period can be ascribed to multiplying partnerships among research institutions, escalating demand for precise and early diagnostic approaches, a surge in autoimmune and inflammatory disorders incidents, initiatives by government and healthcare institutions, along with the emergence of telemedicine and digital health platforms. The forecast period will be characterized by major trends such as technological evolutions, strides in diagnostic technologies, custom-tailored treatment plans, as well as innovations in diagnostic tools.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23432&type=smp
Who Are the Leading Companies in the Juvenile Idiopathic Arthritis Diagnostic Market?
Major companies operating in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech , Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, Avecon Healthcare.
What Are the Key Drivers of the Juvenile Idiopathic Arthritis Diagnostic Market?
The escalating incidence of autoimmune disorders is anticipated to drive the growth of the juvenile idiopathic arthritis diagnostic market. Autoimmune disorders are conditions where the immune system erroneously attacks healthy cells in the body, leading to inflammation, tissue damage, and ongoing health issues. The uptick in autoimmune diseases is tied to a complicated interweaving of environmental factors, genetic tendencies, and changes in lifestyle. These diseases trigger juvenile idiopathic arthritis (JIA) when the immune system wrongly targets synovial tissue in the joints, resulting in inflammation and harm. For example, data from Versorgungsatlas.de, an interactive online platform from Germany, showed that in November 2024, out of 73,241,305 insured people in 2022, 6,304,340 were identified with at least one autoimmune disease. This translates to a raw prevalence rate of 8.61%. Consequently, the rising incidence of autoimmune disorders is fuelling the expansion of the juvenile idiopathic arthritis diagnostic market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=23432&type=smp
What Are the Key Market Segments in the Juvenile Idiopathic Arthritis Diagnostic Industry?
The juvenile idiopathic arthritis diagnostic market covered in this report is segmented –
1) By Type: Serological Tests, Imaging Tests, Genetic Tests
2) By Technology: Molecular Diagnostics, Immunoassays, Flow Cytometry
3) By Services: Diagnostic Services, Consultation Services, Laboratory Services
4) By Application: Hospital Laboratories, Diagnostic Centres, Research Institutes
Subsegments:
1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing
What Are the Latest Trends in the Juvenile Idiopathic Arthritis Diagnostic Market?
Prominent corporations within the juvenile idiopathic arthritis diagnostic market are concentrating on strategic alliances to broaden their product range, enhance their research skills, and fortify their global market presence. These strategic alliances typically involve cooperation between firms with the aim of improving early detection and diagnosis. For example, Augurex Life Sciences Corp., a biotechnology firm based in Canada, teamed up with Quest Diagnostics, a diagnostic services firm based in the United States, in November 2024. The aim was to better the detection and management of rheumatoid arthritis (RA) through the use of the 14-3-3η (eta) biomarker. As part of this partnership, Quest Diagnostics will confirm and offer a lab-developed test in the United States utilizing Augurex’s 14-3-3η biomarker. The purpose of this test is to identify raised levels of the 14-3-3η protein, which is associated with rheumatoid arthritis and correlates with an increased risk and severity of joint damage.
Access The Full Report Here:
What Are the Key Regional Markets in the Juvenile Idiopathic Arthritis Diagnostic Industry?
North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the juvenile idiopathic arthritis diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23432
This Report Delivers Insight On:
1. How big is the juvenile idiopathic arthritis diagnostic market, and how is it changing globally?
2. Who are the major companies in the juvenile idiopathic arthritis diagnostic market, and how are they performing?
3. What are the key opportunities and risks in the juvenile idiopathic arthritis diagnostic market right now?
4. Which products or customer segments are growing the most in the juvenile idiopathic arthritis diagnostic market?
5. What factors are helping or slowing down the growth of the juvenile idiopathic arthritis diagnostic market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
